AMY SCHEFLER to Combined Modality Therapy
This is a "connection" page, showing publications AMY SCHEFLER has written about Combined Modality Therapy.
Connection Strength
0.196
-
Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes. Am J Ophthalmol. 2020 08; 216:165-173.
Score: 0.077
-
Extraocular extension of uveal melanoma after fine-needle aspiration, vitrectomy, and open biopsy. JAMA Ophthalmol. 2013 Sep; 131(9):1220-4.
Score: 0.049
-
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology. 2007 Jan; 114(1):162-9.
Score: 0.030
-
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol. 2012 Jan; 130(1):57-64.
Score: 0.011
-
Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma. J Pediatr Ophthalmol Strabismus. 2010 Sep 22; 47 Online:e1-5.
Score: 0.010
-
Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina. 2010 Apr; 30(4 Suppl):S66-8.
Score: 0.010
-
Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi. J Cataract Refract Surg. 2008 Oct; 34(10):1669-73.
Score: 0.009